Monsanto (NYSE:MON)‘s stock had its “hold” rating reissued by stock analysts at Royal Bank Of Canada in a research report issued on Wednesday, November 15th. They presently have a $128.00 target price on the basic materials company’s stock. Royal Bank Of Canada’s target price would indicate a potential upside of 7.63% from the company’s previous close.
Several other research firms have also weighed in on MON. Zacks Investment Research lowered shares of Monsanto from a “buy” rating to a “hold” rating in a research report on Tuesday, September 12th. Wells Fargo & Company increased their price target on shares of Monsanto from $107.50 to $118.00 and gave the stock a “market perform” rating in a report on Tuesday, October 10th. UBS downgraded shares of Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 target price on the stock. in a research note on Friday, August 18th. BidaskClub raised shares of Monsanto from a “sell” rating to a “hold” rating in a research note on Saturday, August 19th. Finally, Barclays reiterated an “equal weight” rating and set a $124.00 price target (up from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. Eleven research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $124.61.
Shares of Monsanto (MON) opened at $118.93 on Wednesday. The stock has a market cap of $52,093.27, a P/E ratio of 21.40, a P/E/G ratio of 1.70 and a beta of 1.04. Monsanto has a 1-year low of $103.08 and a 1-year high of $122.79. The company has a current ratio of 1.35, a quick ratio of 0.83 and a debt-to-equity ratio of 1.12.
Monsanto (NYSE:MON) last released its earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.41) by $0.61. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The company had revenue of $2.69 billion for the quarter, compared to the consensus estimate of $2.51 billion. During the same quarter in the previous year, the company earned $0.07 EPS. Monsanto’s quarterly revenue was up 4.8% compared to the same quarter last year. research analysts anticipate that Monsanto will post 5.74 earnings per share for the current fiscal year.
In other Monsanto news, CFO Pierre Courduroux sold 4,320 shares of the stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $122.00, for a total value of $527,040.00. Following the completion of the sale, the chief financial officer now directly owns 48,388 shares in the company, valued at $5,903,336. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Steven Mizell sold 11,526 shares of the stock in a transaction dated Monday, October 9th. The shares were sold at an average price of $119.70, for a total value of $1,379,662.20. The disclosure for this sale can be found here. Insiders have sold a total of 49,236 shares of company stock worth $5,931,934 in the last three months. Corporate insiders own 0.79% of the company’s stock.
Large investors have recently made changes to their positions in the company. Vanguard Group Inc. grew its holdings in Monsanto by 2.6% in the second quarter. Vanguard Group Inc. now owns 30,725,725 shares of the basic materials company’s stock valued at $3,636,697,000 after purchasing an additional 784,418 shares during the period. BlackRock Inc. grew its holdings in Monsanto by 6.5% in the second quarter. BlackRock Inc. now owns 27,898,255 shares of the basic materials company’s stock valued at $3,302,038,000 after purchasing an additional 1,705,439 shares during the period. State Street Corp grew its holdings in Monsanto by 0.6% in the second quarter. State Street Corp now owns 20,276,780 shares of the basic materials company’s stock valued at $2,399,965,000 after purchasing an additional 122,814 shares during the period. Capital International Investors grew its holdings in Monsanto by 10.3% in the third quarter. Capital International Investors now owns 9,344,430 shares of the basic materials company’s stock valued at $1,119,650,000 after purchasing an additional 872,377 shares during the period. Finally, Northern Trust Corp grew its holdings in Monsanto by 0.7% in the second quarter. Northern Trust Corp now owns 7,092,929 shares of the basic materials company’s stock valued at $839,519,000 after purchasing an additional 47,725 shares during the period. Hedge funds and other institutional investors own 76.00% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This article was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this article on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark laws. The original version of this article can be read at https://www.dispatchtribunal.com/2017/12/02/monsantos-mon-hold-rating-reaffirmed-at-royal-bank-of-canada.html.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.